Lupin launches generic Solodyn
Lupin is debuting its generic Solodyn (minocycline hydrochloride extended-release tablets) in a 55-mg dosage strength, having received approval from the Food and Drug Administration earlier.
Lupin’s generic of Medicis Pharmaceutical’s branded drug is indicated to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older.
Minocycline hydrochloride ER tablets had a market value of approximately $76.8 million, according to December 2018 IQVIA data.
Lupin’s generic of Medicis Pharmaceutical’s branded drug is indicated to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older.
Minocycline hydrochloride ER tablets had a market value of approximately $76.8 million, according to December 2018 IQVIA data.